April 17, 2021 07:48 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengal polls: ECI serves notice to TMC candidate Sujata Mondal over her remarks against Schedule Caste community | Covid-19 is primarily airborne, safety protocol should be changed urgently: Lancet study | Maharashtra, Delhi record highest-ever one-day Covid spike | Bengal polls: Left candidate in Murshidabad's Jangipur AC Pradip Nandi succumbs to Covid-19 | UK government clears Nirav Modi's extradition to India

Centre ropes in more PSUs, pumps money to increase Bharat Biotech's Covaxin production to 10 crore per month by Sept

New Delhi/IBNS: Amid the steep rise in Covid-19 cases, the Centre on Friday said it is taking steps to increase and accelerate the production of indigenous vaccines under Atma Nirbhar Bharat 3.0 Mission COVID Suraksha.

Brazil denies permission to import Bharat Biotech developed Covaxin

New Delhi/IBNS:  Brazil's health regulator has denied permission to import Covaxin, the coronavirus vaccine developed by India's indigenous firm Bharat Biotech.

Covaxin taken off clinical trial mode, no consent forms required

New Delhi/IBNS: Pharmaceutical company Bharat Biotech's indigenous Coronavirus vaccine-Covaxin-has been taken off the clinical trial mode, which means beneficiaries will not have to sign consent forms before taking the drug.

COVAXIN is 81 pct effective: Bharat Biotech 

Hyderabad: Bharat Biotech, a global leader in vaccine innovation,developing vaccines for infectious diseases, today announced the first interim analysis of itsBBV152 (COVAXIN) where it showed it was 81 percent effective. 

Covid-19 vaccination drive starts in Assam

Guwahati/UNI: The Covid-19 vaccination drive started in Assam on Saturday along with other parts of the country.

Congress MP Manish Tewari questions roll out of Covaxin

New Delhi/IBNS: Congress leader Manish Tewari has raised questions over unavailability of options in choosing the Coronavirus vaccine, according to media reports.

Covid-19: Bharat Biotech rolls out India's indigenous vaccine Covaxin

Hyderabad/IBNS: A day after the Serum Institute of India (SII) rolled out its vaccine against Covid-19, the first batch of India's indigenous remedy Covaxin, made by Bharat Biotech, left Hyderabad for 11 cities on Wednesday morning, media reports said.

Bharat Biotech announces completion of phase 3 clinical trials of Covid-19 vaccine

New Delhi/UNI: Bharat Biotech on Thursday announced that it has enrolled 25,800 volunteers for phase 3 clinical trials of its indigenously manufactured Covid-19 vaccine, 'Covaxin'.

Don't accuse us of inexperience, we are a global company: Bharat Biotech Chairman to critics of Covaxin

New Delhi/IBNS: Chairman of Bharat Biotech- whose coronavirus vaccine Covaxin has been permitted for "restricted use in an emergency situation in public interest"- on Monday hit out at its critics and said 'don't accuse us of inexperience.'

Expert panel recommends approval for Bharat Biotech's Covaxin

New Delhi/IBNS: A government-appointed panel of experts on Saturday cleared  emergency use of indigenous COVID-19 vaccine Covaxin manufactured by Hyderabad-based Bharat Biotech, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).

Govt's expert panel clears Oxford COVID-19 vaccine for India

New Delhi/IBNS: A government-appointed panel of experts on Friday cleared the Oxford COVID-19 vaccine manufactured by the Serum Institute of India, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).

Govt's expert panel to meet over Covid-19 vaccine approval today

New Delhi/IBNS: An expert panel, appointed by the central government, will on Friday meet over the approval for an emergency use of three Covid-19 vaccines, including an indigenous one.

After Pfizer and Serum Institute, Bharat Biotech seeks DCGI approval for emergency use of Covaxin

New Delhi/IBNS:  After Pfizer and Serum Institute, Hyderabad-based pharmaceutical company Bharat Biotech has sought approval from the Drug Controller General of India (DCGI) for the emergency use authorisation (EUA) of its Covid-19 vaccine-Covaxin, media reports said.

India's Covid-19 vaccine candidate 'Covaxin' gets clearance for Phase 3 clinical trials

New Delhi/IBNS: In a ray of hope, India's coronavirus vaccine named 'Covaxin', being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials.

Bharat Biotech's vaccine candidate shows 'robust immune responses' in animal study

New Delhi/IBNS: Bharat Biotech that has been working on coronavirus vaccine COVAXIN has said a study on animals has shown that the vaccine candidate has helped develop a strong immune response to the highly infectious pathogen.